Contineum Therapeutics, Inc. (CTNM)

CIK 1855175 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Contineum Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G0000315066-26-002728
Nov 4, 20261440001950047-26-010677
Nov 3, 202610-Q0001628280-26-069515
Nov 3, 20268-K0001628280-26-069493
Oct 28, 2026SCHEDULE 13G0002050709-26-000029
Oct 28, 2026SCHEDULE 13G/A0000038777-26-000276
Oct 22, 2026SCHEDULE 13G0001493152-26-048104
Oct 1, 20261440001950047-26-009932
Sep 14, 20268-K0001628280-26-061834
Sep 8, 20261440001950047-26-009206
Sep 8, 202640001628280-26-060962
Sep 1, 20261440001950047-26-008923
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003422
Aug 3, 202640001628280-26-052031
Aug 3, 20261440001950047-26-007509
Aug 3, 20261440001950047-26-007517
Jul 30, 202610-Q0001628280-26-051054
Jul 30, 20268-K0001628280-26-051051
Jul 27, 2026SCHEDULE 13G0002012383-26-002243
Jul 17, 2026SCHEDULE 13G/A0001104659-26-084693
Jul 13, 20268-K0001628280-26-048023
Jul 10, 202640001628280-26-047909
Jul 8, 202640001628280-26-047710
Jul 8, 20261440001950047-26-006968
Jul 2, 202640001628280-26-047058